Your browser doesn't support javascript.
loading
Acceptability of Four Intervention Components Supporting Medication Adherence in Women with Breast Cancer: a Process Evaluation of a Fractional Factorial Pilot Optimization Trial.
Green, Sophie M C; Rousseau, Nikki; Hall, Louise H; French, David P; Graham, Christopher D; Lloyd, Kelly E; Collinson, Michelle; Ow, Pei Loo; Taylor, Christopher; Howdon, Daniel; Foy, Robbie; Walwyn, Rebecca; Clark, Jane; Parbutt, Catherine; Waller, Jo; Buxton, Jacqueline; Moore, Sally J L; Velikova, Galina; Farrin, Amanda; Smith, Samuel G.
Afiliación
  • Green SMC; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL. S.m.c.green@leeds.ac.uk.
  • Rousseau N; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
  • Hall LH; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
  • French DP; Manchester Centre for Health Psychology, University of Manchester, Manchester, UK, M13 9PL.
  • Graham CD; Department of Psychological Sciences & Health, University of Strathclyde, Glasgow, G1 1QE, Scotland.
  • Lloyd KE; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
  • Collinson M; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
  • Ow PL; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
  • Taylor C; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
  • Howdon D; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
  • Foy R; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK, LS2 9NL.
  • Walwyn R; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
  • Clark J; Department of Clinical and Health Psychology, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.
  • Parbutt C; Medicines Management and Pharmacy Services, Leeds Teaching Hospitals NHS Trust, Leeds, LS9 7TF, UK.
  • Waller J; Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Buxton J; Independent, Leeds, UK.
  • Moore SJL; Independent, Leeds, UK.
  • Velikova G; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK, LS9 7TF.
  • Farrin A; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, UK, LS9 7TF.
  • Smith SG; Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK, LS2 9NL.
Prev Sci ; 2024 Jul 26.
Article en En | MEDLINE | ID: mdl-39060840
ABSTRACT
Adjuvant endocrine therapy (AET) reduces mortality in early-stage breast cancer, but adherence is low. We developed a multicomponent intervention to support AET adherence comprising text messages, information leaflet, acceptance and commitment therapy (ACT), and side-effect website. Guided by the multiphase optimization strategy, the intervention components were tested in the ROSETA pilot optimization trial. Our mixed-methods process evaluation investigated component acceptability. The pilot optimization trial used a 24-1 fractional factorial design. Fifty-two women prescribed AET were randomized to one of eight experimental conditions, containing unique component combinations. An acceptability questionnaire was administered 4 months post-randomization, and semi-structured interviews with 20 participants further explored acceptability. Assessments were guided by four constructs of the theoretical framework of acceptability affective attitude, burden, perceived effectiveness, and coherence. Quantitative and qualitative findings were triangulated to identify agreements/disagreements. There were high overall acceptability scores (median = 14-15/20, range = 11-20). There was agreement between the qualitative and quantitative findings when triangulated. Most participants "liked" or "strongly liked" all components and reported they required low effort to engage in. Between 50% (leaflet) and 65% (SMS) "agreed" or "strongly agreed," it was clear how each component would help adherence. Perceived effectiveness was mixed, with 35.0% (text messages) to 55.6% (ACT) of participants "agreeing" or "strongly agreeing" that each component would improve their adherence. Interview data provided suggestions for improvements. The four components were acceptable to women with breast cancer and will be refined. Mixed-methods and triangulation were useful methodological approaches and could be applied in other optimization trial process evaluations.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Prev Sci Asunto de la revista: CIENCIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Prev Sci Asunto de la revista: CIENCIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos